nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—Isopropamide—Benzphetamine—obesity	0.154	0.348	CrCrCtD
Darifenacin—Diphenidol—Benzphetamine—obesity	0.106	0.239	CrCrCtD
Darifenacin—Fentanyl—Benzphetamine—obesity	0.0942	0.213	CrCrCtD
Darifenacin—Methadone—Benzphetamine—obesity	0.0885	0.2	CrCrCtD
Darifenacin—CYP2D6—Phentermine—obesity	0.0442	0.157	CbGbCtD
Darifenacin—CYP2D6—Bupropion—obesity	0.0376	0.133	CbGbCtD
Darifenacin—CYP3A4—Sibutramine—obesity	0.0371	0.131	CbGbCtD
Darifenacin—CYP2D6—Methamphetamine—obesity	0.0354	0.125	CbGbCtD
Darifenacin—CYP3A4—Benzphetamine—obesity	0.0281	0.0996	CbGbCtD
Darifenacin—CYP2D6—Cimetidine—obesity	0.0276	0.0977	CbGbCtD
Darifenacin—CYP3A4—Bupropion—obesity	0.0239	0.0847	CbGbCtD
Darifenacin—CYP3A4—Orlistat—obesity	0.0195	0.069	CbGbCtD
Darifenacin—CYP3A4—Cimetidine—obesity	0.0176	0.0621	CbGbCtD
Darifenacin—CYP3A4—Topiramate—obesity	0.0115	0.0407	CbGbCtD
Darifenacin—Loperamide—POMC—obesity	0.000631	0.537	CrCbGaD
Darifenacin—Vomiting—Phenylpropanolamine—obesity	0.000405	0.0026	CcSEcCtD
Darifenacin—Dizziness—Phentermine—obesity	0.000403	0.00259	CcSEcCtD
Darifenacin—Rash—Phenylpropanolamine—obesity	0.000402	0.00258	CcSEcCtD
Darifenacin—Dermatitis—Phenylpropanolamine—obesity	0.000401	0.00258	CcSEcCtD
Darifenacin—Bronchitis—Bupropion—obesity	0.000397	0.00255	CcSEcCtD
Darifenacin—Sinusitis—Sibutramine—obesity	0.000397	0.00255	CcSEcCtD
Darifenacin—Vaginal infection—Topiramate—obesity	0.000396	0.00255	CcSEcCtD
Darifenacin—Pharyngitis—Orlistat—obesity	0.000389	0.0025	CcSEcCtD
Darifenacin—Dry eye—Topiramate—obesity	0.000388	0.00249	CcSEcCtD
Darifenacin—Vomiting—Phentermine—obesity	0.000388	0.00249	CcSEcCtD
Darifenacin—Urinary tract disorder—Orlistat—obesity	0.000387	0.00249	CcSEcCtD
Darifenacin—Oedema peripheral—Orlistat—obesity	0.000386	0.00248	CcSEcCtD
Darifenacin—Urethral disorder—Orlistat—obesity	0.000384	0.00247	CcSEcCtD
Darifenacin—Rash—Phentermine—obesity	0.000384	0.00247	CcSEcCtD
Darifenacin—Dermatitis—Phentermine—obesity	0.000384	0.00247	CcSEcCtD
Darifenacin—Headache—Phentermine—obesity	0.000382	0.00245	CcSEcCtD
Darifenacin—Erectile dysfunction—Bupropion—obesity	0.000381	0.00245	CcSEcCtD
Darifenacin—Rhinitis—Sibutramine—obesity	0.00038	0.00245	CcSEcCtD
Darifenacin—Mouth ulceration—Topiramate—obesity	0.000379	0.00244	CcSEcCtD
Darifenacin—Bladder pain—Topiramate—obesity	0.000379	0.00244	CcSEcCtD
Darifenacin—Nausea—Phenylpropanolamine—obesity	0.000378	0.00243	CcSEcCtD
Darifenacin—Pharyngitis—Sibutramine—obesity	0.000377	0.00242	CcSEcCtD
Darifenacin—Weight increased—Bupropion—obesity	0.000376	0.00242	CcSEcCtD
Darifenacin—Oedema peripheral—Sibutramine—obesity	0.000374	0.0024	CcSEcCtD
Darifenacin—Hypersensitivity—Cimetidine—obesity	0.000372	0.00239	CcSEcCtD
Darifenacin—Infestation NOS—Bupropion—obesity	0.000368	0.00237	CcSEcCtD
Darifenacin—Infestation—Bupropion—obesity	0.000368	0.00237	CcSEcCtD
Darifenacin—Abnormal vision—Topiramate—obesity	0.000366	0.00235	CcSEcCtD
Darifenacin—Visual impairment—Sibutramine—obesity	0.000366	0.00235	CcSEcCtD
Darifenacin—Mental disability—Topiramate—obesity	0.000364	0.00234	CcSEcCtD
Darifenacin—Diarrhoea—Diethylpropion—obesity	0.000363	0.00233	CcSEcCtD
Darifenacin—Nausea—Phentermine—obesity	0.000362	0.00233	CcSEcCtD
Darifenacin—Asthenia—Cimetidine—obesity	0.000362	0.00233	CcSEcCtD
Darifenacin—Stomatitis—Bupropion—obesity	0.000359	0.00231	CcSEcCtD
Darifenacin—Urinary tract infection—Bupropion—obesity	0.000358	0.0023	CcSEcCtD
Darifenacin—Eye disorder—Sibutramine—obesity	0.000355	0.00228	CcSEcCtD
Darifenacin—Mediastinal disorder—Orlistat—obesity	0.000353	0.00227	CcSEcCtD
Darifenacin—Sweating—Bupropion—obesity	0.000353	0.00227	CcSEcCtD
Darifenacin—Dizziness—Diethylpropion—obesity	0.000351	0.00225	CcSEcCtD
Darifenacin—Sinusitis—Bupropion—obesity	0.000346	0.00222	CcSEcCtD
Darifenacin—Diarrhoea—Cimetidine—obesity	0.000345	0.00222	CcSEcCtD
Darifenacin—Angiopathy—Sibutramine—obesity	0.000344	0.00221	CcSEcCtD
Darifenacin—Mental disorder—Orlistat—obesity	0.000344	0.00221	CcSEcCtD
Darifenacin—Vomiting—Diethylpropion—obesity	0.000337	0.00217	CcSEcCtD
Darifenacin—Flatulence—Orlistat—obesity	0.000336	0.00216	CcSEcCtD
Darifenacin—Rash—Diethylpropion—obesity	0.000334	0.00215	CcSEcCtD
Darifenacin—Dysgeusia—Orlistat—obesity	0.000334	0.00215	CcSEcCtD
Darifenacin—Dermatitis—Diethylpropion—obesity	0.000334	0.00215	CcSEcCtD
Darifenacin—Dizziness—Cimetidine—obesity	0.000334	0.00214	CcSEcCtD
Darifenacin—Headache—Diethylpropion—obesity	0.000332	0.00214	CcSEcCtD
Darifenacin—Rhinitis—Bupropion—obesity	0.000332	0.00213	CcSEcCtD
Darifenacin—Back pain—Orlistat—obesity	0.00033	0.00212	CcSEcCtD
Darifenacin—Hallucination—Bupropion—obesity	0.000329	0.00212	CcSEcCtD
Darifenacin—Pharyngitis—Bupropion—obesity	0.000328	0.00211	CcSEcCtD
Darifenacin—Urinary tract disorder—Bupropion—obesity	0.000327	0.0021	CcSEcCtD
Darifenacin—Oedema peripheral—Bupropion—obesity	0.000326	0.00209	CcSEcCtD
Darifenacin—Flatulence—Sibutramine—obesity	0.000325	0.00209	CcSEcCtD
Darifenacin—Urethral disorder—Bupropion—obesity	0.000324	0.00208	CcSEcCtD
Darifenacin—Dysgeusia—Sibutramine—obesity	0.000323	0.00208	CcSEcCtD
Darifenacin—Vision blurred—Orlistat—obesity	0.000322	0.00207	CcSEcCtD
Darifenacin—Visual disturbance—Topiramate—obesity	0.000321	0.00207	CcSEcCtD
Darifenacin—Vomiting—Cimetidine—obesity	0.000321	0.00206	CcSEcCtD
Darifenacin—Back pain—Sibutramine—obesity	0.00032	0.00205	CcSEcCtD
Darifenacin—Visual impairment—Bupropion—obesity	0.000319	0.00205	CcSEcCtD
Darifenacin—Rash—Cimetidine—obesity	0.000318	0.00204	CcSEcCtD
Darifenacin—Dermatitis—Cimetidine—obesity	0.000318	0.00204	CcSEcCtD
Darifenacin—Headache—Cimetidine—obesity	0.000316	0.00203	CcSEcCtD
Darifenacin—Nausea—Diethylpropion—obesity	0.000315	0.00202	CcSEcCtD
Darifenacin—Erythema multiforme—Bupropion—obesity	0.000313	0.00201	CcSEcCtD
Darifenacin—Angioedema—Orlistat—obesity	0.000312	0.002	CcSEcCtD
Darifenacin—Vision blurred—Sibutramine—obesity	0.000311	0.002	CcSEcCtD
Darifenacin—Eye disorder—Bupropion—obesity	0.000309	0.00199	CcSEcCtD
Darifenacin—Angioedema—Sibutramine—obesity	0.000302	0.00194	CcSEcCtD
Darifenacin—Palpitations—Orlistat—obesity	0.000302	0.00194	CcSEcCtD
Darifenacin—Angiopathy—Bupropion—obesity	0.0003	0.00193	CcSEcCtD
Darifenacin—Nausea—Cimetidine—obesity	0.0003	0.00193	CcSEcCtD
Darifenacin—Mediastinal disorder—Bupropion—obesity	0.000298	0.00192	CcSEcCtD
Darifenacin—Cough—Orlistat—obesity	0.000298	0.00191	CcSEcCtD
Darifenacin—Syncope—Sibutramine—obesity	0.000296	0.0019	CcSEcCtD
Darifenacin—Face oedema—Topiramate—obesity	0.000294	0.00189	CcSEcCtD
Darifenacin—Palpitations—Sibutramine—obesity	0.000292	0.00188	CcSEcCtD
Darifenacin—Loss of consciousness—Sibutramine—obesity	0.00029	0.00187	CcSEcCtD
Darifenacin—Mental disorder—Bupropion—obesity	0.00029	0.00186	CcSEcCtD
Darifenacin—Urinary retention—Topiramate—obesity	0.00029	0.00186	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000289	0.00185	CcSEcCtD
Darifenacin—Cough—Sibutramine—obesity	0.000288	0.00185	CcSEcCtD
Darifenacin—Hypertension—Sibutramine—obesity	0.000285	0.00183	CcSEcCtD
Darifenacin—Dry mouth—Orlistat—obesity	0.000284	0.00183	CcSEcCtD
Darifenacin—Flatulence—Bupropion—obesity	0.000284	0.00182	CcSEcCtD
Darifenacin—Dysgeusia—Bupropion—obesity	0.000282	0.00181	CcSEcCtD
Darifenacin—Arthralgia—Sibutramine—obesity	0.000281	0.00181	CcSEcCtD
Darifenacin—Oedema—Orlistat—obesity	0.000279	0.00179	CcSEcCtD
Darifenacin—Anaphylactic shock—Orlistat—obesity	0.000279	0.00179	CcSEcCtD
Darifenacin—Back pain—Bupropion—obesity	0.000279	0.00179	CcSEcCtD
Darifenacin—Infection—Orlistat—obesity	0.000277	0.00178	CcSEcCtD
Darifenacin—Breast disorder—Topiramate—obesity	0.000275	0.00177	CcSEcCtD
Darifenacin—Dry mouth—Sibutramine—obesity	0.000275	0.00177	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Topiramate—obesity	0.000274	0.00176	CcSEcCtD
Darifenacin—Nervous system disorder—Orlistat—obesity	0.000273	0.00176	CcSEcCtD
Darifenacin—Confusional state—Sibutramine—obesity	0.000272	0.00175	CcSEcCtD
Darifenacin—Vision blurred—Bupropion—obesity	0.000271	0.00174	CcSEcCtD
Darifenacin—Skin disorder—Orlistat—obesity	0.000271	0.00174	CcSEcCtD
Darifenacin—Anaphylactic shock—Sibutramine—obesity	0.00027	0.00173	CcSEcCtD
Darifenacin—Oedema—Sibutramine—obesity	0.00027	0.00173	CcSEcCtD
Darifenacin—Hyperhidrosis—Orlistat—obesity	0.000269	0.00173	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Topiramate—obesity	0.000269	0.00173	CcSEcCtD
Darifenacin—Infection—Sibutramine—obesity	0.000268	0.00172	CcSEcCtD
Darifenacin—Shock—Sibutramine—obesity	0.000265	0.0017	CcSEcCtD
Darifenacin—Angioedema—Bupropion—obesity	0.000263	0.00169	CcSEcCtD
Darifenacin—Tachycardia—Sibutramine—obesity	0.000263	0.00169	CcSEcCtD
Darifenacin—Skin disorder—Sibutramine—obesity	0.000262	0.00168	CcSEcCtD
Darifenacin—Hyperhidrosis—Sibutramine—obesity	0.000261	0.00168	CcSEcCtD
Darifenacin—Syncope—Bupropion—obesity	0.000258	0.00166	CcSEcCtD
Darifenacin—Palpitations—Bupropion—obesity	0.000254	0.00164	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Orlistat—obesity	0.000254	0.00163	CcSEcCtD
Darifenacin—Bronchitis—Topiramate—obesity	0.000253	0.00163	CcSEcCtD
Darifenacin—Loss of consciousness—Bupropion—obesity	0.000253	0.00163	CcSEcCtD
Darifenacin—Insomnia—Orlistat—obesity	0.000252	0.00162	CcSEcCtD
Darifenacin—Cough—Bupropion—obesity	0.000251	0.00162	CcSEcCtD
Darifenacin—Hypertension—Bupropion—obesity	0.000249	0.0016	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Sibutramine—obesity	0.000246	0.00158	CcSEcCtD
Darifenacin—Dyspepsia—Orlistat—obesity	0.000245	0.00158	CcSEcCtD
Darifenacin—Arthralgia—Bupropion—obesity	0.000245	0.00158	CcSEcCtD
Darifenacin—Insomnia—Sibutramine—obesity	0.000244	0.00157	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000243	0.00156	CcSEcCtD
Darifenacin—Erectile dysfunction—Topiramate—obesity	0.000243	0.00156	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Orlistat—obesity	0.00024	0.00155	CcSEcCtD
Darifenacin—Dyspnoea—Sibutramine—obesity	0.00024	0.00154	CcSEcCtD
Darifenacin—Dry mouth—Bupropion—obesity	0.00024	0.00154	CcSEcCtD
Darifenacin—Somnolence—Sibutramine—obesity	0.00024	0.00154	CcSEcCtD
Darifenacin—Weight increased—Topiramate—obesity	0.00024	0.00154	CcSEcCtD
Darifenacin—Pain—Orlistat—obesity	0.000238	0.00153	CcSEcCtD
Darifenacin—Dyspepsia—Sibutramine—obesity	0.000237	0.00153	CcSEcCtD
Darifenacin—Confusional state—Bupropion—obesity	0.000237	0.00152	CcSEcCtD
Darifenacin—Anaphylactic shock—Bupropion—obesity	0.000235	0.00151	CcSEcCtD
Darifenacin—Oedema—Bupropion—obesity	0.000235	0.00151	CcSEcCtD
Darifenacin—Infestation—Topiramate—obesity	0.000235	0.00151	CcSEcCtD
Darifenacin—Infestation NOS—Topiramate—obesity	0.000235	0.00151	CcSEcCtD
Darifenacin—Infection—Bupropion—obesity	0.000233	0.0015	CcSEcCtD
Darifenacin—Clotrimazole—CYP19A1—obesity	0.000233	0.199	CrCbGaD
Darifenacin—Gastrointestinal disorder—Sibutramine—obesity	0.000233	0.0015	CcSEcCtD
Darifenacin—Shock—Bupropion—obesity	0.000231	0.00149	CcSEcCtD
Darifenacin—Pain—Sibutramine—obesity	0.000231	0.00148	CcSEcCtD
Darifenacin—Constipation—Sibutramine—obesity	0.000231	0.00148	CcSEcCtD
Darifenacin—Nervous system disorder—Bupropion—obesity	0.00023	0.00148	CcSEcCtD
Darifenacin—Feeling abnormal—Orlistat—obesity	0.00023	0.00148	CcSEcCtD
Darifenacin—Tachycardia—Bupropion—obesity	0.000229	0.00147	CcSEcCtD
Darifenacin—Stomatitis—Topiramate—obesity	0.000229	0.00147	CcSEcCtD
Darifenacin—Skin disorder—Bupropion—obesity	0.000228	0.00147	CcSEcCtD
Darifenacin—Urinary tract infection—Topiramate—obesity	0.000228	0.00147	CcSEcCtD
Darifenacin—Gastrointestinal pain—Orlistat—obesity	0.000228	0.00146	CcSEcCtD
Darifenacin—Hyperhidrosis—Bupropion—obesity	0.000227	0.00146	CcSEcCtD
Darifenacin—Feeling abnormal—Sibutramine—obesity	0.000222	0.00143	CcSEcCtD
Darifenacin—Gastrointestinal pain—Sibutramine—obesity	0.00022	0.00142	CcSEcCtD
Darifenacin—Sinusitis—Topiramate—obesity	0.00022	0.00142	CcSEcCtD
Darifenacin—Abdominal pain—Orlistat—obesity	0.00022	0.00142	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Bupropion—obesity	0.000214	0.00138	CcSEcCtD
Darifenacin—Abdominal pain—Sibutramine—obesity	0.000213	0.00137	CcSEcCtD
Darifenacin—Insomnia—Bupropion—obesity	0.000213	0.00137	CcSEcCtD
Darifenacin—Rhinitis—Topiramate—obesity	0.000211	0.00136	CcSEcCtD
Darifenacin—Hallucination—Topiramate—obesity	0.00021	0.00135	CcSEcCtD
Darifenacin—Dyspnoea—Bupropion—obesity	0.00021	0.00135	CcSEcCtD
Darifenacin—Pharyngitis—Topiramate—obesity	0.000209	0.00134	CcSEcCtD
Darifenacin—Somnolence—Bupropion—obesity	0.000209	0.00134	CcSEcCtD
Darifenacin—Urinary tract disorder—Topiramate—obesity	0.000208	0.00134	CcSEcCtD
Darifenacin—Oedema peripheral—Topiramate—obesity	0.000208	0.00133	CcSEcCtD
Darifenacin—Dyspepsia—Bupropion—obesity	0.000207	0.00133	CcSEcCtD
Darifenacin—Urethral disorder—Topiramate—obesity	0.000207	0.00133	CcSEcCtD
Darifenacin—Hypersensitivity—Orlistat—obesity	0.000205	0.00132	CcSEcCtD
Darifenacin—Visual impairment—Topiramate—obesity	0.000203	0.00131	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Bupropion—obesity	0.000203	0.0013	CcSEcCtD
Darifenacin—Pain—Bupropion—obesity	0.000201	0.00129	CcSEcCtD
Darifenacin—Constipation—Bupropion—obesity	0.000201	0.00129	CcSEcCtD
Darifenacin—Asthenia—Orlistat—obesity	0.0002	0.00128	CcSEcCtD
Darifenacin—Erythema multiforme—Topiramate—obesity	0.000199	0.00128	CcSEcCtD
Darifenacin—Hypersensitivity—Sibutramine—obesity	0.000199	0.00128	CcSEcCtD
Darifenacin—Pruritus—Orlistat—obesity	0.000197	0.00127	CcSEcCtD
Darifenacin—Eye disorder—Topiramate—obesity	0.000197	0.00127	CcSEcCtD
Darifenacin—Feeling abnormal—Bupropion—obesity	0.000194	0.00124	CcSEcCtD
Darifenacin—Asthenia—Sibutramine—obesity	0.000193	0.00124	CcSEcCtD
Darifenacin—Gastrointestinal pain—Bupropion—obesity	0.000192	0.00124	CcSEcCtD
Darifenacin—Angiopathy—Topiramate—obesity	0.000191	0.00123	CcSEcCtD
Darifenacin—Pruritus—Sibutramine—obesity	0.000191	0.00123	CcSEcCtD
Darifenacin—Diarrhoea—Orlistat—obesity	0.000191	0.00123	CcSEcCtD
Darifenacin—Mediastinal disorder—Topiramate—obesity	0.00019	0.00122	CcSEcCtD
Darifenacin—Abdominal pain—Bupropion—obesity	0.000186	0.00119	CcSEcCtD
Darifenacin—Mental disorder—Topiramate—obesity	0.000185	0.00119	CcSEcCtD
Darifenacin—Diarrhoea—Sibutramine—obesity	0.000184	0.00119	CcSEcCtD
Darifenacin—Dizziness—Orlistat—obesity	0.000184	0.00118	CcSEcCtD
Darifenacin—Flatulence—Topiramate—obesity	0.000181	0.00116	CcSEcCtD
Darifenacin—Dysgeusia—Topiramate—obesity	0.00018	0.00115	CcSEcCtD
Darifenacin—Dizziness—Sibutramine—obesity	0.000178	0.00115	CcSEcCtD
Darifenacin—Back pain—Topiramate—obesity	0.000177	0.00114	CcSEcCtD
Darifenacin—Vomiting—Orlistat—obesity	0.000177	0.00114	CcSEcCtD
Darifenacin—Rash—Orlistat—obesity	0.000176	0.00113	CcSEcCtD
Darifenacin—Dermatitis—Orlistat—obesity	0.000175	0.00113	CcSEcCtD
Darifenacin—Headache—Orlistat—obesity	0.000175	0.00112	CcSEcCtD
Darifenacin—Clotrimazole—CYP2E1—obesity	0.000174	0.148	CrCbGaD
Darifenacin—Hypersensitivity—Bupropion—obesity	0.000173	0.00111	CcSEcCtD
Darifenacin—Vision blurred—Topiramate—obesity	0.000173	0.00111	CcSEcCtD
Darifenacin—Vomiting—Sibutramine—obesity	0.000171	0.0011	CcSEcCtD
Darifenacin—Rash—Sibutramine—obesity	0.00017	0.00109	CcSEcCtD
Darifenacin—Dermatitis—Sibutramine—obesity	0.00017	0.00109	CcSEcCtD
Darifenacin—Headache—Sibutramine—obesity	0.000169	0.00109	CcSEcCtD
Darifenacin—Asthenia—Bupropion—obesity	0.000169	0.00108	CcSEcCtD
Darifenacin—Pruritus—Bupropion—obesity	0.000166	0.00107	CcSEcCtD
Darifenacin—Nausea—Orlistat—obesity	0.000165	0.00106	CcSEcCtD
Darifenacin—Syncope—Topiramate—obesity	0.000165	0.00106	CcSEcCtD
Darifenacin—Palpitations—Topiramate—obesity	0.000162	0.00104	CcSEcCtD
Darifenacin—Loss of consciousness—Topiramate—obesity	0.000161	0.00104	CcSEcCtD
Darifenacin—Diarrhoea—Bupropion—obesity	0.000161	0.00103	CcSEcCtD
Darifenacin—Nausea—Sibutramine—obesity	0.00016	0.00103	CcSEcCtD
Darifenacin—Cough—Topiramate—obesity	0.00016	0.00103	CcSEcCtD
Darifenacin—Hypertension—Topiramate—obesity	0.000158	0.00102	CcSEcCtD
Darifenacin—Arthralgia—Topiramate—obesity	0.000156	0.001	CcSEcCtD
Darifenacin—Dizziness—Bupropion—obesity	0.000155	0.000999	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000155	0.000997	CcSEcCtD
Darifenacin—Dry mouth—Topiramate—obesity	0.000153	0.000982	CcSEcCtD
Darifenacin—Confusional state—Topiramate—obesity	0.000151	0.00097	CcSEcCtD
Darifenacin—Oedema—Topiramate—obesity	0.00015	0.000962	CcSEcCtD
Darifenacin—Vomiting—Bupropion—obesity	0.000149	0.00096	CcSEcCtD
Darifenacin—Infection—Topiramate—obesity	0.000149	0.000956	CcSEcCtD
Darifenacin—Rash—Bupropion—obesity	0.000148	0.000952	CcSEcCtD
Darifenacin—Dermatitis—Bupropion—obesity	0.000148	0.000952	CcSEcCtD
Darifenacin—Shock—Topiramate—obesity	0.000147	0.000947	CcSEcCtD
Darifenacin—Headache—Bupropion—obesity	0.000147	0.000946	CcSEcCtD
Darifenacin—Nervous system disorder—Topiramate—obesity	0.000147	0.000944	CcSEcCtD
Darifenacin—Tachycardia—Topiramate—obesity	0.000146	0.000939	CcSEcCtD
Darifenacin—Skin disorder—Topiramate—obesity	0.000145	0.000935	CcSEcCtD
Darifenacin—Hyperhidrosis—Topiramate—obesity	0.000145	0.00093	CcSEcCtD
Darifenacin—Nausea—Bupropion—obesity	0.00014	0.000897	CcSEcCtD
Darifenacin—Methadone—CYP19A1—obesity	0.000137	0.116	CrCbGaD
Darifenacin—Musculoskeletal discomfort—Topiramate—obesity	0.000136	0.000877	CcSEcCtD
Darifenacin—Insomnia—Topiramate—obesity	0.000135	0.00087	CcSEcCtD
Darifenacin—Dyspnoea—Topiramate—obesity	0.000133	0.000858	CcSEcCtD
Darifenacin—Somnolence—Topiramate—obesity	0.000133	0.000856	CcSEcCtD
Darifenacin—Dyspepsia—Topiramate—obesity	0.000132	0.000847	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Topiramate—obesity	0.000129	0.000831	CcSEcCtD
Darifenacin—Pain—Topiramate—obesity	0.000128	0.000823	CcSEcCtD
Darifenacin—Constipation—Topiramate—obesity	0.000128	0.000823	CcSEcCtD
Darifenacin—Feeling abnormal—Topiramate—obesity	0.000123	0.000793	CcSEcCtD
Darifenacin—Gastrointestinal pain—Topiramate—obesity	0.000122	0.000787	CcSEcCtD
Darifenacin—Abdominal pain—Topiramate—obesity	0.000118	0.000761	CcSEcCtD
Darifenacin—Hypersensitivity—Topiramate—obesity	0.00011	0.000709	CcSEcCtD
Darifenacin—Asthenia—Topiramate—obesity	0.000107	0.000691	CcSEcCtD
Darifenacin—Pruritus—Topiramate—obesity	0.000106	0.000681	CcSEcCtD
Darifenacin—Diarrhoea—Topiramate—obesity	0.000102	0.000658	CcSEcCtD
Darifenacin—Dizziness—Topiramate—obesity	9.9e-05	0.000636	CcSEcCtD
Darifenacin—Vomiting—Topiramate—obesity	9.52e-05	0.000612	CcSEcCtD
Darifenacin—Rash—Topiramate—obesity	9.44e-05	0.000607	CcSEcCtD
Darifenacin—Dermatitis—Topiramate—obesity	9.43e-05	0.000606	CcSEcCtD
Darifenacin—Headache—Topiramate—obesity	9.38e-05	0.000603	CcSEcCtD
Darifenacin—Nausea—Topiramate—obesity	8.89e-05	0.000572	CcSEcCtD
Darifenacin—CHRM1—Signaling Pathways—C3—obesity	5.18e-06	4.39e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR2A—obesity	5.17e-06	4.38e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—C3—obesity	5.16e-06	4.37e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYCS—obesity	5.15e-06	4.37e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3R1—obesity	5.13e-06	4.35e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NOS3—obesity	5.13e-06	4.35e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR2A—obesity	5.12e-06	4.34e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—C3—obesity	5.11e-06	4.33e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PIK3CA—obesity	5.1e-06	4.32e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GGT1—obesity	5.06e-06	4.29e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GOT1—obesity	5.06e-06	4.29e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC22A1—obesity	5.05e-06	4.28e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CLOCK—obesity	5.05e-06	4.28e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARG—obesity	5e-06	4.24e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NCOA1—obesity	4.98e-06	4.22e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CB—obesity	4.94e-06	4.19e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MTOR—obesity	4.94e-06	4.19e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—POMC—obesity	4.94e-06	4.18e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SULT2A1—obesity	4.93e-06	4.17e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GLP1R—obesity	4.93e-06	4.17e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IRS2—obesity	4.92e-06	4.17e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AGT—obesity	4.92e-06	4.17e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—STK11—obesity	4.91e-06	4.16e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP19A1—obesity	4.91e-06	4.16e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IRS2—obesity	4.91e-06	4.16e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—INS—obesity	4.91e-06	4.16e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AGT—obesity	4.9e-06	4.15e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PIK3CA—obesity	4.88e-06	4.14e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IRS2—obesity	4.86e-06	4.12e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AGT—obesity	4.86e-06	4.11e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DPYD—obesity	4.85e-06	4.11e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOE—obesity	4.82e-06	4.08e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—LEP—obesity	4.82e-06	4.08e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LEP—obesity	4.8e-06	4.07e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOE—obesity	4.8e-06	4.07e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CAV1—obesity	4.77e-06	4.05e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOA1—obesity	4.76e-06	4.04e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CAV1—obesity	4.76e-06	4.03e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOE—obesity	4.76e-06	4.03e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LEP—obesity	4.76e-06	4.03e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOA1—obesity	4.75e-06	4.02e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MTOR—obesity	4.73e-06	4.01e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CB—obesity	4.73e-06	4.01e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CAV1—obesity	4.71e-06	3.99e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOA1—obesity	4.7e-06	3.99e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PRKAR2B—obesity	4.66e-06	3.95e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DCN—obesity	4.63e-06	3.92e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ESR1—obesity	4.6e-06	3.9e-05	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—AKT1—obesity	4.59e-06	3.89e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ESR1—obesity	4.59e-06	3.89e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—COMT—obesity	4.56e-06	3.87e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CD—obesity	4.56e-06	3.86e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRKCB—obesity	4.54e-06	3.85e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—F2—obesity	4.54e-06	3.85e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ESR1—obesity	4.54e-06	3.85e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—F2—obesity	4.53e-06	3.84e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRKCB—obesity	4.53e-06	3.84e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—obesity	4.52e-06	3.83e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CPT1A—obesity	4.51e-06	3.82e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARGC1A—obesity	4.5e-06	3.81e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GNB3—obesity	4.5e-06	3.81e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—obesity	4.5e-06	3.81e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BAD—obesity	4.49e-06	3.81e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—F2—obesity	4.49e-06	3.8e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRKCB—obesity	4.49e-06	3.8e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—HMOX1—obesity	4.48e-06	3.8e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BAD—obesity	4.48e-06	3.79e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BAD—obesity	4.43e-06	3.76e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NAMPT—obesity	4.42e-06	3.74e-05	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—AKT1—obesity	4.39e-06	3.72e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—LIPC—obesity	4.39e-06	3.72e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GCK—obesity	4.39e-06	3.72e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GNAS—obesity	4.38e-06	3.71e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOC3—obesity	4.36e-06	3.7e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CG—obesity	4.35e-06	3.69e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CG—obesity	4.34e-06	3.67e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—obesity	4.32e-06	3.67e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—NOS3—obesity	4.3e-06	3.65e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3R1—obesity	4.3e-06	3.65e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IRS1—obesity	4.3e-06	3.64e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—obesity	4.3e-06	3.64e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CG—obesity	4.29e-06	3.64e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOB—obesity	4.29e-06	3.64e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IRS1—obesity	4.29e-06	3.63e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IRS1—obesity	4.24e-06	3.6e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CETP—obesity	4.24e-06	3.59e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SDC1—obesity	4.19e-06	3.55e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK8—obesity	4.18e-06	3.54e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—AKT1—obesity	4.17e-06	3.53e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—POMC—obesity	4.14e-06	3.51e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—POMC—obesity	4.13e-06	3.5e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AKR1C3—obesity	4.12e-06	3.49e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—INS—obesity	4.12e-06	3.49e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—obesity	4.11e-06	3.49e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—INS—obesity	4.1e-06	3.48e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—LPL—obesity	4.1e-06	3.47e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—POMC—obesity	4.09e-06	3.46e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—INS—obesity	4.06e-06	3.44e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SCARB1—obesity	4.06e-06	3.44e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL2—obesity	4.05e-06	3.43e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL2—obesity	4.04e-06	3.42e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK8—obesity	4e-06	3.39e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL2—obesity	4e-06	3.39e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GPX1—obesity	4e-06	3.39e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—AKT1—obesity	3.99e-06	3.38e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1—obesity	3.98e-06	3.37e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AKT2—obesity	3.98e-06	3.37e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CB—obesity	3.97e-06	3.37e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1—obesity	3.97e-06	3.36e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AKT2—obesity	3.97e-06	3.36e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SREBF1—obesity	3.94e-06	3.34e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—obesity	3.94e-06	3.34e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1—obesity	3.93e-06	3.33e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AKT2—obesity	3.93e-06	3.33e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CD36—obesity	3.89e-06	3.3e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GOT2—obesity	3.83e-06	3.25e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CD—obesity	3.82e-06	3.24e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT3—obesity	3.82e-06	3.24e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CD—obesity	3.81e-06	3.23e-05	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PIK3CA—obesity	3.79e-06	3.21e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SERPINE1—obesity	3.78e-06	3.2e-05	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PIK3CA—obesity	3.77e-06	3.2e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CD—obesity	3.77e-06	3.2e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SERPINE1—obesity	3.77e-06	3.19e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—FASN—obesity	3.75e-06	3.18e-05	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PIK3CA—obesity	3.74e-06	3.17e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—BCHE—obesity	3.73e-06	3.16e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SERPINE1—obesity	3.73e-06	3.16e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MTHFR—obesity	3.69e-06	3.13e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TYK2—obesity	3.68e-06	3.12e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TYK2—obesity	3.67e-06	3.11e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT3—obesity	3.66e-06	3.1e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RHOA—obesity	3.65e-06	3.09e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RHOA—obesity	3.64e-06	3.08e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TYK2—obesity	3.63e-06	3.08e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARA—obesity	3.62e-06	3.07e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3R1—obesity	3.61e-06	3.06e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOS3—obesity	3.61e-06	3.06e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP2E1—obesity	3.6e-06	3.05e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RHOA—obesity	3.6e-06	3.05e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3R1—obesity	3.6e-06	3.05e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOS3—obesity	3.6e-06	3.05e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3R1—obesity	3.56e-06	3.02e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOS3—obesity	3.56e-06	3.02e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NQO1—obesity	3.56e-06	3.02e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MYC—obesity	3.55e-06	3.01e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TGFB1—obesity	3.54e-06	3e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AGT—obesity	3.51e-06	2.97e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PIK3CA—obesity	3.44e-06	2.91e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOE—obesity	3.44e-06	2.91e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PIK3CA—obesity	3.43e-06	2.91e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GCG—obesity	3.41e-06	2.89e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC2A4—obesity	3.41e-06	2.89e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAV1—obesity	3.4e-06	2.88e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MYC—obesity	3.4e-06	2.88e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOA1—obesity	3.4e-06	2.88e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PIK3CA—obesity	3.39e-06	2.88e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TGFB1—obesity	3.39e-06	2.87e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYCS—obesity	3.37e-06	2.86e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MTOR—obesity	3.33e-06	2.82e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CB—obesity	3.33e-06	2.82e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CB—obesity	3.32e-06	2.82e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MTOR—obesity	3.32e-06	2.82e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GOT1—obesity	3.31e-06	2.8e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GGT1—obesity	3.31e-06	2.8e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MTOR—obesity	3.29e-06	2.79e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CB—obesity	3.29e-06	2.79e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NCOA1—obesity	3.26e-06	2.76e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP19A1—obesity	3.21e-06	2.72e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—STK11—obesity	3.21e-06	2.72e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CG—obesity	3.1e-06	2.63e-05	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—AKT1—obesity	3.09e-06	2.62e-05	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—AKT1—obesity	3.08e-06	2.61e-05	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—AKT1—obesity	3.05e-06	2.59e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—obesity	3.05e-06	2.58e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—obesity	3.04e-06	2.57e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CA—obesity	3.01e-06	2.55e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—obesity	3.01e-06	2.55e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARG—obesity	2.99e-06	2.54e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—COMT—obesity	2.98e-06	2.53e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—POMC—obesity	2.95e-06	2.5e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GNB3—obesity	2.94e-06	2.49e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARGC1A—obesity	2.94e-06	2.49e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—INS—obesity	2.93e-06	2.49e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HMOX1—obesity	2.93e-06	2.48e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—obesity	2.9e-06	2.45e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—obesity	2.89e-06	2.45e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CA—obesity	2.89e-06	2.45e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GNAS—obesity	2.87e-06	2.43e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—obesity	2.86e-06	2.42e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK8—obesity	2.82e-06	2.39e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—AKT1—obesity	2.81e-06	2.38e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK8—obesity	2.81e-06	2.38e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOB—obesity	2.81e-06	2.38e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—AKT1—obesity	2.8e-06	2.37e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK8—obesity	2.78e-06	2.36e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—AKT1—obesity	2.77e-06	2.35e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CD—obesity	2.73e-06	2.31e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—obesity	2.69e-06	2.28e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—LPL—obesity	2.68e-06	2.27e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—obesity	2.67e-06	2.26e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPX1—obesity	2.61e-06	2.22e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT3—obesity	2.58e-06	2.18e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3R1—obesity	2.57e-06	2.18e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NOS3—obesity	2.57e-06	2.18e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT3—obesity	2.57e-06	2.18e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—obesity	2.55e-06	2.17e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CD36—obesity	2.55e-06	2.16e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT3—obesity	2.54e-06	2.15e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AKT1—obesity	2.46e-06	2.09e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CA—obesity	2.42e-06	2.05e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MTHFR—obesity	2.41e-06	2.04e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MYC—obesity	2.39e-06	2.03e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TGFB1—obesity	2.39e-06	2.02e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MYC—obesity	2.39e-06	2.02e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TGFB1—obesity	2.38e-06	2.02e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CB—obesity	2.38e-06	2.01e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARA—obesity	2.37e-06	2.01e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MYC—obesity	2.36e-06	2e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AKT1—obesity	2.36e-06	2e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TGFB1—obesity	2.36e-06	2e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—obesity	2.35e-06	1.99e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AGT—obesity	2.29e-06	1.94e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOE—obesity	2.25e-06	1.9e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAV1—obesity	2.23e-06	1.89e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOA1—obesity	2.22e-06	1.88e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CA—obesity	2.03e-06	1.72e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CG—obesity	2.03e-06	1.72e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CA—obesity	2.03e-06	1.72e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CA—obesity	2.01e-06	1.7e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—AKT1—obesity	1.98e-06	1.68e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARG—obesity	1.96e-06	1.66e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—POMC—obesity	1.93e-06	1.63e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—INS—obesity	1.92e-06	1.63e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—obesity	1.8e-06	1.52e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—obesity	1.79e-06	1.52e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CD—obesity	1.78e-06	1.51e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—obesity	1.78e-06	1.5e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—obesity	1.76e-06	1.49e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NOS3—obesity	1.68e-06	1.43e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3R1—obesity	1.68e-06	1.43e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AKT1—obesity	1.66e-06	1.41e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AKT1—obesity	1.65e-06	1.4e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AKT1—obesity	1.64e-06	1.39e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CB—obesity	1.55e-06	1.32e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—obesity	1.54e-06	1.3e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CA—obesity	1.45e-06	1.23e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AKT1—obesity	1.18e-06	1e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CA—obesity	9.47e-07	8.02e-06	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AKT1—obesity	7.73e-07	6.55e-06	CbGpPWpGaD
